Commentary on "Quantifying the value of human life

Area of Science:

• Health Economics
• Bioethics
• Pharmacoeconomics

Background:

• The high cost of medical interventions necessitates robust cost-benefit analyses.
• Sandoz's Clozaril and its associated blood monitoring program presented significant allocation challenges.
• Ethical considerations are paramount when assigning economic value to human life.

Purpose of the Study:

• To propose a cost-benefit analysis framework for allocating resources in healthcare.
• To address ethical dilemmas in quantifying the value of human life for cost accounting.
• To evaluate the application of such analyses to specific pharmaceutical programs.

Main Methods:

• Cost-benefit analysis framework development.
• Ethical analysis of value-of-life calculations.
• Case study application to a pharmaceutical blood monitoring program.

Main Results:

• The article demonstrates how cost-benefit analysis can be applied to complex ethical questions in healthcare allocation.
• It highlights that seemingly objective analyses are influenced by underlying value judgments.
• Specific allocation issues related to expensive monitoring programs are addressed.

Conclusions:

• Cost-benefit analysis, while a valuable tool, must acknowledge inherent ethical values.
• The quantification of human life value for accounting purposes requires careful ethical consideration.
• Arnold's approach provides a method for navigating these complex issues in pharmaceutical economics.